Assignee
F STAR THERAPEUTICS LTD
GB·4 granted patents·6 pending applications·5 citations·filing 2017–2023
Top patents by PatentIndex Score
10 records- 0185US12187798B2LAG-3 binding membersF STAR THERAPEUTICS LTD·Filed 2021·Granted Jan 7, 2025·1 cites·24 claims
- 0282US12103976B2Fc binding fragments comprising a CD137 antigen-binding siteF STAR THERAPEUTICS LTD·Filed 2019·Granted Oct 1, 2024·4 cites·22 claims
- 0381US2023340696A1Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regionsF STAR THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 0478US2024150495A1Novel Multivalent ImmunoglobulinsF STAR THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 0570US11499249B2Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regionsF STAR THERAPEUTICS LTD·Filed 2019·Granted Nov 15, 2022·0 cites·13 claims
- 0663US2023406935A1Fc binding fragments comprising a pd-l1 antigen-binding siteF STAR THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 0761US11827720B2Multivalent immunoglobulinsF STAR THERAPEUTICS LTD·Filed 2017·Granted Nov 28, 2023·0 cites·5 claims
- 0861US2023357413A1Egfr binding moleculesF STAR THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 0961US2022185894A1Binding molecules binding pd-l1 and lag-3F STAR THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1045US2022275092A1Dosage regimes for the administration of a lag-3/pd-l1 bispecific antibodyF STAR THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →